Many of the previously described mechanisms related to SGLT2 inhibition in HF, including reducing fibrosis, improving myocardial energetics, and cardiorenal axis protection are believed to apply to HFpEF (Faluk et al., 2024; Ostrominski & Vaduganathan, 2024). Here, SLC5A2 is linked to hydrops fetalis.